Valuation | Industry Range | |
---|---|---|
Price / Earnings | 0.93 |   |
Book Value | -2.83 |   |
Earnings Per Share | -$1.79 |   |
Price To Sales Ratio | 10.17 |   |
Price To Book Ratio | 4.23 |   |
Price To Tangible Book Ratio | 4.23 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 183.8M |   |
Float (MRQ) | 95.98% |   |
Shares Outstanding (MRQ) | 62.6M |   |
Short Interest as a % of Float (MRQ) | 18.72% |   |
Shares Held By Institutions (MRQ) | 30.3M |   |
Margins | Industry Range | |
---|---|---|
Sales | $79.9M |   |
Gross Margin | 97.11% |   |
Net Profit Margin | -167.35% |   |
EBIT Margin | -144.91% |   |
EBITDA Margin | -143.20% |   |
Operating Margins | -144.91% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 4.79 |   |
Quick Ratio (MRQ) | 4.79 |   |
Total Debt/Equity Ratio (MRQ) | 1,462.74 |   |
Debt/Common Equity Ratio (MRQ) | 1,462.74 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | 75.62% |   |
Return on Assets | -91.55% |   |
Asset Turnover | 0.55 |   |
Receivables Turnover | 1.80 |   |
Inventory Turnover | 3.20 |   |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | -228.75% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*OMER does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.21%